TY  - CHAP
AU  - Ameer L. Elaimy
AU  - Linda Ding
AU  - Carla Bradford
AU  - Yansong Geng
AU  - Harry Bushe
AU  - I-Lin Kuo
AU  - Yankhua Fan
AU  - Fenhong Liu
AU  - Abdulnasser Khalifeh
AU  - Suhong Yu
AU  - Jonathan Saleeby
AU  - James Shen
AU  - Kevin O’Connor
AU  - Kenneth Ulin
ED  - Thomas J. FitzGerald
ED  - Maryann Bishop-Jodoin
Y1  - 2021-08-18
PY  - 2021
T1  - History and Overview of Proton Therapy
N2  - Over the past twenty-five years, proton therapy has become more prominent worldwide. It is an important component of clinical radiation therapy for both adult and pediatric clinical care. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology. As such, <i>Proton Therapy - Current Status and Future Directions</i> reviews many aspects of proton care including the application of protons in modern clinical trials. It also reviews problems associated with the migration of proton care worldwide and examines the future direction of proton care. This project was created by colleagues at IntechOpen and was carefully managed by Romina Rovan. It has been a privilege to help coordinate the text and chapters designed to acknowledge the history, footprint, and growing interest of proton care worldwide. Proton management is now embedded in the clinical trials process. In pediatric care, proton delivery is embedded with photons for the management of pediatric malignancies and adult groups have initiated proton-specific clinical trials. A proton registry has been established and outcomes are under evaluation. Due to the inherent ability of protons to spare normal tissue, protons will continue to develop and become increasingly important in radiation oncology.
BT  - Proton Therapy
SP  - Ch. 1
UR  - https://doi.org/10.5772/intechopen.95959
DO  - 10.5772/intechopen.95959
SN  - 978-1-83968-013-7
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-23
ER  -